PMC · DOI:10.3390/pharmaceutics18020209·February 6, 2026
Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines
Antonio Lopalco, Nunzio Denora

Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical studies and practices · Pharmacogenetics and Drug Metabolism · Biosimilars and Bioanalytical Methods
